Sign inJoin waitlistJoin the waitlist

Keng

Hematology · University of Virginia Physicians Group

Credentials: · · · · ·

History

Research

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning
Experimental Hematology · 2003 · 82 citations
MLL-Rearranged Acute Lymphoblastic Leukemia
Review · Current Hematologic Malignancy Reports · 2020 · 69 citations
Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department
Journal of Oncology Practice · 2015 · First of 18 authors · 48 citations

Daniel Reed
11 papers · 5 as a fellow
Firas El Chaer
9 papers
Mikkael Sekeres
6 papers
EP
Eric Pierce
4 papers · 2 as a fellow
Joseph Mort
4 papers · 4 as a resident
Matt Kalaycio
3 papers
Aziz Nazha
2 papers · 1 as a resident
BM
Benjamin Mautner
2 papers · 1 as a resident
Bhagirathbhai Dholaria
2 papers
Bradley Yelvington
2 papers
Clayton Jackson
2 papers
EM
Erin Mcloughlin
2 papers · 2 as a fellow

Clinical trials

Cardioprotection in AML
Principal investigator · Recruiting · Phase 2
University of Virginia
2022–2028
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Site PI · Recruiting · Phase 1
Keystone Nano, Inc
2025–2026
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Site PI · Recruiting · Phase 1, Phase 2
Delta-Fly Pharma, Inc.
2024–2026
A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML
Site PI · Unknown · Phase 1, Phase 2
BioSight Ltd.
2022–2025